Prognostic value of histopathologic features with respect to disease course in children with juvenile dermatomyositis by Lopez-Martinez Annette Y, Miles Lili, Huang Bin, Bove Kevin, Lovell Daniel J

Connect to this object online.

Summary of worldwide pediatric malignancies reported after exposure to etanercept by Chernyukhin Nataliya, Stryker Scott, Lovell Daniel J, Wallace Carol A, McCroskery Peter, Blosch Consuelo, Zack Debra J

Connect to this object online.

Understanding the biology and use of anti-TNF agents in JIA - interim results by Lovell Daniel J, Spalding Steven P, Onel Karen, Gottlieb Beth S, Brunner Hermine I, Kimura Yukiko, Morris Paula W, Olson Judyann C, Johnson Anne, Giannini Edward H

Connect to this object online.

MRI findings from the trial of early aggressive therapy (TREAT) study by Thapa Mahesh, Spalding Steven J, Hashkes Philip J, Ringold Sarah, Zeft Andrew S, Sundel Robert P, Otto Randolph K, Giannini Edward H, Lovell Daniel J, Wallace Carol A

Connect to this object online.

The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trial by Gerloni Valeria, Fasth Anders, Baildam Eileen, Apaz Maria T, Gattorno Marco, Espada Graciela, Woo Patricia, Cuttica Ruben, Petty Ross, Martini Alberto, Lovell Daniel J, Marini Joseph C, Wagner Carrie, Visvanathan Sudha, Lahdenne Pekka, Quartier Pierre, Saurenmann Rotraud, Travers Suzanne, Mendelsohn Alan, Xu Stephen, Giannini Edward H, Ruperto Nicolino

Connect to this object online.

The effects of early aggressive therapy in JIA: results of the TREAT study by Wallace Carol A, Giannini Edward H, Spalding Steven J, Hashkes Philip J, O'Neil Kathleen M, Zeft Andrew S, Szer Ilona S, Ringold Sarah M, Brunner Hermine, Schanberg Laura E, Sundel Robert P, Milojevic Diana, Punaro Marilynn G, Chira Peter, Gottlieb Beth S, Higgins Gloria C, Ilowite Norman T, Kimura Yukiko, Huang Bin, Lovell Daniel J

Connect to this object online.